ArticleJAAD internationalPublished
Postmarketing safety of bimekizumab for hidradenitis suppurativa: An early pharmacovigilance analysis using the United States Food and Drug Administration Adverse Event Reporting System
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, University of Pennsylvania. Affiliation source
Publication record
- Type
- Article
- Venue
- JAAD international
- Published
- Topic
- Public health
- Subject terms
- Pharmacovigilance; Hidradenitis Suppurativa; Biologic Agents; Faers Database; Il-17 Inhibitors; Bimekizumab
- PubMed ID
- 41969289
- PubMed Central ID
- PMC13069420
- Open access
- Yes, open
- Added to directory
- Source checked